← All trials
NCT05886829
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 27, 2022
- Primary completion
- Jan 19, 2023
- Completion date
- Feb 1, 2023
- First posted
- Jun 2, 2023
- Last posted
- Jun 2, 2023
- Enrollment
- 157
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Ferrer LaboratoriesLead sponsor
- Hospital CEMESA Cortés, San Pedro Sula, HondurasCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.